Pharmaceutical

AlzeCure Presents New Anti-Inflammatory Data with NeuroRestore ACD856 at the Alzheimer’s Conference CTAD

STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

1 year ago

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

HAMBURG, GERMANY / ACCESSWIRE / October 30, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) will announce its financial…

1 year ago

Medexus Schedules Second Fiscal Quarter 2025 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 29, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host…

1 year ago

10x Genomics Reports Third Quarter 2024 Financial Results

PLEASANTON, Calif., Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,…

1 year ago

The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance

NORTHAMPTON, MA / ACCESSWIRE / October 29, 2024 / Diversity and inclusion are not only core elements of Teva's cultural…

1 year ago

Synoligo Biotechnologies Unveils New Facility to Enhance Oligonucleotide Synthesis Capacity

MORRISVILLE, N.C., Oct. 29, 2024 /PRNewswire/ -- Synoligo Biotechnologies Inc., a Contract Research and Development Organization (CRDO) based in Research…

1 year ago

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO…

1 year ago

QuantalX Introduces a Breakthrough in the Diagnosis and Classification of Parkinson’s Disease

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the…

1 year ago

CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool – a first-of-its-kind capability in the world of scientific technology solutions

The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio,…

1 year ago

Top 10 Pharma Selects TrueMed for Advanced Counterfeit Drug Investigations

HELSINKI, Oct. 29, 2024 /PRNewswire/ -- TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership…

1 year ago